Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Many hair loss myths lack strong evidence, but some treatments are proven to work.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Diuretics can cause serious side effects and should be used carefully.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.